First cattle maternal vaccine effectively proven to protect against Cryptosporidium parvum in calves from birth onwards RAHWAY, N.J.,– Oct. 5, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BOVILIS CRYPTIUM®, […]
Company Reiterates a Commitment to Zero Dog-Mediated Human Rabies Deaths by 2030 RAHWAY, N.J., September 28, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than 5 million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. The goal […]
Symposium highlights data on an innovative, aqueous suspension of fluralaner for subcutaneous injection that was recently approved in Australia Scientific sessions highlight the importance of the One Health commitment to people, animals, environment Featured studies provide insights for otitis externa treatment, parasite prevention and infectious disease prevention RAHWAY, NJ — Sept. 27, 2023 – MSD […]
Study published in Infection and Immunity Currently no vaccine and few treatments available for cryptosporidiosis, a significant diarrheal disease in both people and animals worldwide RAHWAY, N.J., September 20, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of a new study that demonstrates […]
INNOVAX®-ILT-IBD, the first vaccine to prevent ILT, IBD, and MD in a single dose, now available in the EU, will be highlighted in a symposium Multiple studies continue to support the benefit of INNOVAX®-ND-IBD, the first vaccine against classic and variant IBD, ND and MD in a single dose RAHWAY, N.J., August 29, 2023 – […]
Gp40 antigen vaccine elicits immune response against Cryptosporidium parvum in pregnant cows to protect their newborn calves through antibodies in colostrum Combined data represent first efficacious C. parvum maternal vaccine worldwide for any species RAHWAY, N.J., August 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced […]
Biomass estimation unit provides key information about average weight, distribution, and growth trends RAHWAY, N.J., August 21, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the launch of FALCON® Biomass, a powerful, always-on biomass estimation unit that provides key information about average weight, distribution, and […]
First EU-licensed poultry vaccine to prevent development of ILT, IBD and MD without the risk of reversion to virulence of ILT Rahway, N.J., June 12, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today that the European Commission has approved INNOVAX®-ILT-IBD, a dual-construct HVT vaccine that provides […]
Multiple studies demonstrate the benefit of needle-free vaccination for the prevention and management of Lawsonia intracellularis Additional novel research includes reproductive health, preventive farm care and herd health management MADISON, N.J., May 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of 19 […]
Novel injectable suspension delivers ongoing efficacy against fleas and ticks for dogs six months and older in a single dose MADISON, N.J., May 1, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved a novel injectable […]